NEWS
You can follow the latest news of MicroViable in this section
Microviable Therapeutics attends Bio Europe 2019, the most important continental forum in the field of Biotechnology
Microviable Therapeutics and the Asturian biotechs Entrechem and Dreamgenics participate in the 25th edition of Bio Europe 2019 (Hamburg), the most important continental event in the field of life sciences and that contacts companies with [...]
Gut microbiota analysis for prevent COVID-19. Microviable Therapeutics
Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design a predictive model and open the possibility of designing treatments from Spain. […]
Towards controlling the “second brain” that inhabits your intestines
View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even storing the microbiota for future therapeutic uses. […]
Microviable Therapeutics participates in the ninth edition of Gut Microbiota For Health Summit (GMFH2020)
Microviable Therapeutics, through our CEO Rafael Martínez Permuy, was part of the “Gut Microbiota for Health World Summit” (#GMFH2020) that was held on March 7 and 8 in Madrid, a great international event on microbiota [...]
Microviable Therapeutics pioneer in the field of microbiota.
El Comercio (Diario de Asturias), highlights Microviable’s activity in “the long-term isolation and storage of the microbiota under viable conditions, the analysis of its composition and, finally, the development of microbiome-based therapies. The first two business [...]
Microviable Therapeutics, as part of CSIC stand, participates at the European Forum Transferie 2020
Microviable Therapeutics was in the group of technology-based companies that the CSIC presented at Transfiere 2020, the European Forum for Science, Technology and Innovation, which was held in Malaga on 12 and 13 February. During [...]